Unichem Laboratories gets ANDA approval for Divalproex Sodium Extended-Release Tablets

28 Feb 2022 Evaluate

Unichem Laboratories has received ANDA approval for its Divalproex Sodium Extended-Release Tablets USP, 250 mg and 500 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Depakote ER (Divalproex Sodium) Extended-Release Tablets 250 mg and 500 mg, of AbbVie Inc.

Divalproex Sodium Extended-Release Tablets are indicated for treatment of acute manic or mixed episodes associated with bipolar disorder, as monotherapy and adjunctive therapy and prophylaxis of migraine headaches. The product will be commercialized from Unichem’s Goa Plant.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Unichem Lab Share Price

851.40 -4.70 (-0.55%)
25-Nov-2024 12:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1792.30
Dr. Reddys Lab 1217.40
Cipla 1497.90
Lupin 2107.00
Zydus Lifesciences 956.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.